Favipiravir and ribavirin formulation
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Favipiravir and ribavirin formulation, covering 2021-04-02 to 2021-04-02. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Favipiravir and Ribavirin Formulation for Treatment of COVID-19 [Phase 2, Phase 3]